Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04538768
Other study ID # 20082020
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2020
Est. completion date April 2023

Study information

Verified date August 2020
Source Buccheri La Ferla Hospital, Palermo
Contact Leo Licari, MD
Phone +39 3401710089
Email lele.licari@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine whether the use of the P4HB retro muscular mesh can prevent the lateral incisional hernia after stomal closure.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date April 2023
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients > 18 y.o.

- stomal closure

- elective surgery

Exclusion Criteria:

- patients < 18 y.o.

- emergency surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Mesh augmentation
P4HB retromuscular mesh placement for prevention of lateral incisional hernia after stomal closure
Direct suture
direct fascia suture

Locations

Country Name City State
Italy Ospedale Buccheri La Ferla Palermo Palermo

Sponsors (1)

Lead Sponsor Collaborator
Buccheri La Ferla Hospital, Palermo

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary rate of postoperative lateral incisional hernia after P4HB mesh placement vs direct fascia suture. the outcome 1 will be assessed through clinical examination during follow up time. when the suspicion of incisional hernia will be hypothesized the patients will be conducted to perform US of the abdomen and CT scan of the abdomen if strictly required to confirm the suspicion. 1 week to 18 months after surgery
Secondary surgical operation time in P4HB mesh placement group vs direct fascia suture group. outcome 2 will be assessed through the measurement of the length of surgical operation. The length of the surgical operation will be measured in minutes from the incision of the skin to the suture of the skin. data will be compared with those of the control arm (direct fascia suture) to understand the feasibility of the technique proposed. intraoperative
Secondary length of hospital stay in P4HB mesh placement group vs direct fascia suture group. outcome 3 will be assessed through the measurement of the length of the hospital stay. The length of hospital stay will be measured in days from admission to dimission of the patient. Data will be compared with those of the control arm (direct fascia suture). From the starting date of the study until the date of its completion, assessed up to 18 months"
Secondary rate of surgical site infection in P4HB mesh placement group vs direct fascia suture group. outcome 4 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complication such as surgical site infection. 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
Secondary rate of seroma formation in P4HB mesh placement group vs direct fascia suture group. outcome 5 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as seroma. 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
Secondary rate of hematoma formation in P4HB mesh placement group vs direct fascia suture group. outcome 6 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as hematoma. 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
Secondary assessment of quality of life (QoL) through QoL scale in P4HB mesh placement group vs direct fascia suture group. outcome 7 will be assessed through assessment of the postoperative QoL. The SF-36 questionnaire will be administered post-operatively.
The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life.
The SF-36, as described in the name, is a 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
18 months after surgery.
Secondary cost effectiveness analysis of the P4HB mesh augmentation technique vs direct fascia suture group. the outcome 8 will be assessed through the collection of data about the total costs for the surgical operation and the hospitalization considering materials and mesh used. The analysis will be used to compare the costs of the technique proposed with those of the incisional hernia management in order to conduct a cost effectiveness analysis. through study completion, an average of 1 year .